Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (166K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Graham, S.
Right arrow Articles by Barry, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graham, S.
Right arrow Articles by Barry, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 272-281

Footnote

A promoter directing [alpha] -amanitin-sensitive transcription of GARP, the major surface antigen of insect stage Trypanosoma congolense

A promoter directing [alpha] -amanitin-sensitive transcription of GARP, the major surface antigen of insect stage Trypanosoma congolense Sheila V. Graham , David Jefferies + and J. David Barry*

Wellcome Unit of Molecular Parasitology, The Anderson College, University of Glasgow, 56 Dumbarton Road, Glasgow G11 6NU, UK

Received October 12 1995 ; Revised and Accepted November 29, 1995 GenBank accession nos U35672 and U35856

ABSTRACT

The major surface antigen of procyclic and epimastigote forms of Trypanosoma congolense in the tsetse fly is GARP (glutamic acid/alanine-rich protein), which is thought to be the analogue of procyclin/PARP in Trypanosoma brucei . We have studied two T.congolense GARP loci (the 4.3 and 4.4 loci) whose transcription is [alpha] -amanitin sensitive. Whilst a transcriptional gap 5 ' of the first GARP gene in the cloned region of the 4.4 locus could not be detected, such a gap was present in the 5 ' flank of the first GARP gene in the 4.3 locus. We have located a GARP transcription start site and, using reporter gene constructs containing a putative GARP promoter region in transient transfection studies, we have demonstrated promoter activity for the test region in T.congolense . There are species-specific differences in sequences regulating expression of the two major surface antigens, GARP and procyclin/PARP: the GARP promoter is inactive in T.brucei while the procyclin/PARP promoter is inactive in T.congolense . We have defined the splice acceptor site for the 4.3 GARP gene by sequencing and by 5 ' RT-PCR and demonstrated microheterogeneity in GARP polyadenylation by 3 ' RT-PCR. It appears that some GARP and procyclin/PARP RNA processing signals, although similar, are also species-specific.

INTRODUCTION

Gene organisation in parasitic protozoa of the order Kinetoplastida is unusual among eukaryotes in that genes are usually found grouped together in polycistronic transcription units ( 1 ). Each polycistronic transcription unit has a single 5' promoter, and polycistronic pre-mRNAs are processed by the functionally-linked mechanisms of 5' trans -splicing and 3' polyadenylation ( 2 - 5 ). In many cases genes within a polycistronic transcription unit may be differentially expressed, and therefore regulation of gene expression must take place largely at the post-transcriptional level ( 6 ). Investigation of the mechanisms regulating gene expression in trypanosomes has focused on the African trypanosome Trypanosoma brucei ; very little is known about gene expression in other trypanosomatids and whether this is similar to or different from that in T.brucei .

Another African trypanosome, Trypanosoma congolense (subgenus Nannomonas), has a life cycle similar to that of T.brucei (subgenus Trypanozoon ), with two main phases, one in a mammalian host and the other in the insect vector, the tsetse fly. When T.brucei bloodstream forms enter the tsetse fly midgut, differentiation to the procyclic stage occurs ( 7 ). Concomitant with this transformation, parasites lose the variant surface glycoprotein (VSG) coat, continual switching of which allows antigenic variation in the bloodstream ( 8 ) replacing it with a new, densely packed surface coat composed of procyclin/PARP ( 9 - 12 ). Procyclin/PARP is retained on the surface of insect stage parasites (procyclic and epimastigote) until differentiation to the metacyclic stage occurs in the salivary glands of the fly ( 12 , 13 ). It has been suggested that acquisition of procyclin/PARP might serve to protect the procyclic form from the hostile environment of the tsetse fly midgut and may also have a role in directing differentiating parasites from the midgut to the salivary glands ( 14 , 15 ). The analogue of procyclin/PARP in T.congolense is GARP (glutamic acid/alanine-rich protein) ( 13 , 15 ). GARP displays several features similar to those of procyclin/PARP: the protein is acquired during differentiation from bloodstream to procyclic trypanosomes; it is abundant on the procyclic and epimastigote cell surface ( 13 ); it is acidic and glycosylated ( 13 , 15 ); and is attached to the cell membrane by a GPI anchor (Hulsmeier et al. , unpublished). However, GARP has almost twice the predicted polypeptide molecular mass for procyclin/PARP and has a very different amino acid sequence. DNA fragments homologous to two genomic loci containing at least one GARP gene each have been cloned and characterised ( 15 ) (Fig. 1 ). Sequence analysis has shown that GARP genes display no homology to procyclin/PARP genes except for a 16 nt motif found in the 3' untranslated (UTR) region ( 15 ).


Figure 1 . Maps of the 5' ends of the 4.4 and 4.3 GARP loci and the plasmid subclones derived from these. It is not known from which locus the cDNA clone P4 and the subclone pgarp3'utr are derived. Open boxes: GARP genes; horizontal black bars represent fragments of DNA homologous to the 5' ends of both loci subcloned into pBluescript. Vertical dotted lines delineate the region of 96% homology between the two GARP loci. Abbreviations are: E, Eco RI; H, Hin dIII; Pv, Pvu II; B, Bam HI; Bs, Bst XI.

A procyclin/PARP promoter ( 16 , 17 ) and signals involved in regulating procyclin/PARP RNA processing have been characterised: regulation of procyclin/PARP RNA processing and translation may play a major role in control of procyclin/PARP expression ( 4 , 5 , 18 - 20 ). In T.brucei procyclin/PARP genes (and the VSG genes) are transcribed by an RNA polymerase I-like enzyme which is insensitive to [alpha]-amanitin. The existence of trans -splicing in trypanosomatids means mRNA transcription and capping are not coupled, permitting RNA polymerase I to transcribe protein-coding genes. We wished to begin to understand how regulation of expression of GARP is achieved as a model for understanding control of gene expression in another trypanosome species and to allow us to compare and contrast regulatory mechanisms in gene expression between T.congolense and T.brucei . Study of regulation of gene expression in T.congolense offers a major advantage over such studies in T.brucei since the entire T.congolense life cycle can be achieved in vitro ( 21 - 23 ). We describe here the identification and characterisation of sequences regulating expression of GARP genes, in particular a promoter for GARP gene expression. GARP transcription is [alpha]-amanitin-sensitive. This is the first trypanosomatid promoter identified which directs transcription by an RNA polymerase II-like enzyme. We present evidence that some GARP gene putative regulatory sequences are species-specific: they are not interchangeable with similar regions of sequence from the procyclic/PARP genes from T.brucei .

MATERIALS AND METHODS

Trypanosomes

Cloned lines of T.congolense TREU1457 and 1/148 were used in these studies as described previously ( 15 ). Procyclic populations were grown in Eagle's MEM supplemented with 2 mM Glutamax (Gibco-BRL) and 20% foetal calf serum (JRH Biosciences) at 27oC, in 5% CO 2 .

Recombinant clones

The plasmid subclones generated to perform this work are illustrated in Figure 1 , Figure 3 A and B and Figure 4 A. The routes of construction of each subclone and the specific oligonucleotides used to amplify the inserted DNA in p4.35'flank+SA (Fig. 1 ) and the inserted DNA in p4.35'flank (Fig. 4 A) are available upon request. All constructs are in pBluescript (KS - ) except p4.3garp3'flank which is in pGEM3. The GARP 3'UTR included in pgarp3'utr was derived from the P4 cDNA clone which was isolated from a different stock (1/148) of T.congolense than the genomic DNA-derived subclones (TREU 1457) used in transcriptional analysis. However, the 3'UTR and 620 bp of GARP downstream intergenic region were subsequently subcloned from [lambda]4.3 to give p4.3garp3'flank, and sequencing showed a 96% identity between the sequence of the two UTRs derived from the different stocks.

The recombinant plasmids for transient transfection studies were all derivatives of pJP44, a T.brucei expression construct, which contains, in a 5' to 3' direction, the PARP B promoter, a PARP splice acceptor site, a chloramphenicol acetyl transferase (CAT) reporter gene and the 3' end of the PARP B [alpha] gene to provide polyadenylation signals ( 16 ). The PARP promoter region was the 278 bp Kpn I- Sma I fragment; the splice acceptor region was the 90 bp Sma I- Hin dIII fragment and the 3'UTR was the 360 Bam HI- Pst I fragment ( 16 ). For the GARP constructs the 1095 nt region containing the putative GARP promoter and splice acceptor region was amplified by PCR using the 5'E/Pv Bam HI oligonucleotide (5'-CGCGGATCCACTATCCTCCAACATGTG-3') (Fig. 4 A) and 3'5'congoprom oligonucleotide (5'-AGCTTCGTTGCACAATGTGTG-3') (Fig. 4 A) with Pfu DNA polymerase (Stratagene). The 3'UTR was the 465 bp Bam HI- Kpn I fragment at the 3' end of the GARP cDNA clone P4 (the Kpn I site is in the plasmid polylinker downstream of the 3' insertion site).

Other plasmid clones used were L29, a T.congolense ribosomal protein cDNA clone (R. Bayne, unpublished) pPRO2001, a T.brucei procyclin/PARP cDNA clone ( 9 ), pTb[alpha][beta]-T1, a T.brucei plasmid clone containing an [alpha]- and [beta]-tubulin repeat unit ( 24 ), pR4 a T.brucei ribosomal DNA repeat unit ( 25 ) and pActine, containing a T.brucei actin gene ( 26 ).

DNA sequence analysis

Sequencing was carried out on denatured double-stranded plasmid DNA using the dideoxy chain termination method either conventionally (Sequenase kit: Amersham International) or by polymerase chain reaction cycle sequencing on an Applied Biosystems automated sequencer. Sequence for both strands of recombinant plasmids was obtained using the recommended primers for pBluescript or specific primers synthesised on an Applied Biosystems PCR-mate oligonucleotide synthesiser. Computer analysis was carried out using the GCG sequence analysis software package.

Nuclear run-on analysis

Preparation and storage of nuclei and run-on reactions were carried out exactly as described ( 25 , 27 ). Procyclic run-on reactions were at 27oC, using [alpha]-amanitin at a concentration of 500 [mu]g/ml in methanol. Nuclei (10 9 /reaction) were pre-incubated with the drug in nuclei storage buffer for 10 min on ice ( 27 ). Hybridisations were carried out at 55oC in 3* SSC for 48 h and washes were to 0.1* SSC, 0.1% SDS at 65oC.

Purification of DNA, RNA, Northern and Southern blotting and hybridisation

Standard procedures were used for DNA preparation, gel electrophoresis and Southern blotting onto Hybond N membrane (Amersham International plc). Immobilisation of nucleic acids onto filters was by UV irradiation. RNA was prepared by lithium chloride/urea lysis of trypanosomes followed by phenol extraction ( 28 ). Following DNase I treatment for 1 h in the presence of 100 mM NaCl, 6 mM MgCl 2 and removal of the enzyme by phenol extraction, RNA was fractionated by electrophoresis on denaturing formaldehyde gels following denaturation of 5 [mu]g total RNA by incubation for 10 min in the presence of 50% formamide, 2.2 M formaldehyde ( 29 ). RNA was Northern blotted directly onto Hybond-N membrane and immobilised on the filter by UV irradiation. Radiolabelled probes were prepared by either random hexanucleotide priming of restriction fragments separated by electrophoresis in low melting point gels ( 30 ) or by in vitro transcription of the CAT gene cloned into the vector pBluescript (Stratagene protocol handbook). Hybridisation with the random primed probes was carried out at 42oC in 50% formamide 5* SSC (1* SSC is 150 mM NaCl, 0.015 mM Na citrate), 5* Denhardt's solution, 0.1% SDS, 100 [mu]g/ml herring sperm DNA and blots were washed to 3* SSC or 0.1* SSC, 0.1% SDS at 65oC. Hybridisation with the in vitro transcribed probes was carried out at 55oC in 50% formamide, 5* SET (1* SET is 150 mM NaCl, 10 mM Tris-HCl pH 7.5 and 1 mM EDTA), 5* Denhardt's solution, 50 [mu]g/ml tRNA, 0.5% SDS and washed at 65oC in 0.1* SET, 0.1% SDS. Removal of hybridised probes was carried out as detailed in the Hybond protocol. Following removal of probes filters were autoradiographed to check that no residual hybridisation remained.

RNase protection and in vitro transcription

In vitro transcription was carried out using T3 and T7 RNA polymerases, and the pBluescript recombinant clone, p4.35'flank as described in the Stratagene pBluescript protocol handbook. RNase protection and fractionation of protected fragments was carried out by standard means ( 29 ). Total RNA (10 [mu]g) was hybridised with radiolabelled RNA probes in 80% formamide, 40 mM PIPES, pH 6.4, 400 mM NaCl, 1 mM EDTA at 50oC overnight. Hybrids were digested with RNaseA (10 [mu]g) and RNase T 1 (3 U) for 30 min at 30oC. Protected fragments were fractionated by electrophoresis in a 6% acrylamide, 7 M urea gel, followed by autoradiography.

Transient transfection of trypanosomes

Supercoiled, CsCl-purified plasmid DNA (5 [mu]g for CAT assays or 50 [mu]g for RNA extractions per transfection cuvette) was electroporated into procyclic culture cells exactly as described ( 16 , 31 , 32 ) with a single pulse of 1500 V, 25 [mu]F capacitance from a BioRad Gene Pulser. Following electroporation parasites were transferred to 5 ml Eagle's MEM, 20% foetal calf serum per cuvette and cultured overnight (CAT assays) or 5 h (RNA extractions) at 27oC in 5% CO 2 . CAT reactions were for 2 h at 37oC and assays were by xylene extraction ( 32 , 33 ). Transfections were performed in replicate. RNA was prepared from transiently transfected cells by lysis in 3 M LiCl/6 M urea followed by phenol extraction ( 28 ). Prior to Northern blot analysis RNA was DNase I-treated by incubating up to 50 [mu]g RNA in 100 mM NaCl, 50 mM Tris-HCl pH 8.0, 10 mM MgCl 2 , 40 U RNasin (Promega) and 100 [mu]g/ml DNase I (RNase-free, Life Technologies) in a final volume of 100 [mu]l for 1 h at 37oC followed by phenol/chloroform extraction and ethanol precipitation.

PCR amplification

Using a 5' RACE kit purchased from Life Technologies, 5' RT-PCR was carried out exactly as described in the protocol. The primer for first strand synthesis was GARPgsp1 (5'-GCAGTGTGACCGCCATTAAGTGTAG-3') (Fig. 4 A) which is homologous to sequences 52-27 bp downstream of the start codon for the GARP gene. The cDNAs were purified from primer and unincorporated nucleotides then tailed with an oligo-dC anchor. The first round of amplification was carried out with oligonucleotide GARPgsp2 (5'-CGTTGCACAATGTGTGAAGAGGAGC-3') (Fig. 4 A) which is homologous to sequences 62-88 upstream of the start codon for the GARP gene and the anchor primer supplied with the kit, that contains an oligo-dG anchor region attached to a universal amplification primer region. A second round of PCR was carried out using the oligonucleotide GARPgsp3 (5'-CAAGCAGCGAGCGTGGCG-3') (Fig. 4 A) which is homologous to sequences 103-120 upstream of the start codon for the GARP gene, and the universal amplification primer supplied with the kit. PCR amplification was performed for 35 cycles of 30 s at 94oC, 1 min at 55oC (first round of PCR) and 60oC (second round of PCR), 1 min at 70oC in a final volume of 50 [mu]l containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl 2 , 100 [mu]g/ml BSA, 100 pmol of each primer. PCR products were resolved by gel electrophoresis in 1.5% agarose. PCR products were cloned into a T-vector system (Promega), and recombinant plasmids were sequenced using the dideoxy chain termination method (Sequenase kit: Amersham International).

3 ' RT-PCR

First strand cDNA was synthesised from total RNA isolated from procyclic T.congolense using reverse transcriptase and the oligo [dT]-anchor primer PWM5ANC (5'-CGGTGGCAGCAGCCAACTTTTTTTTTTTT-3') ( 3 ). For determining the wild-type polyadenylation sites for GARP RNAs, cDNAs were PCR-amplified with oligonucleotides PWMEco (5'-CGAGAATTCGGTGGCAGCAGCCAACT-3') an Eco RI-tailed anchor primer homologous to the oligo [dT]-anchor primer ( 3 ) and GARPSG1 (5'-CAGATGGTGCCCGTGCCGTGCTGAC-3') located 80 nt 5' of the GARP stop codon. One further round of amplification was performed with PWMEco and GARPSG2 (5' GAGGCGGGATCCCCCAGCTCA 3') located immediately 3' of the GARP stop codon (Fig. 4 B). For analysis of the polyadenylation site of CAT transcripts expressed from transiently transfected T.congolense, first strand CAT cDNAs were synthesised from total RNA isolated from T.congolense cells transiently transfected with p5'garpCAT3'garp, or p-CAT3'garp as a negative control, and were hybrid-selected prior to amplification, using CAT DNA fragments bound to nylon membrane, to exclude recombination with endogenous GARP transcripts. CAT/GARP chimaeric cDNAs were amplified using oligonucleotides PWMEco (5'-CGAGAATTCGGTGGCAGCAGCAACT-3') ( 3 ) and CATSG4 (5'-GCCCGCCTGATGAATGCTCATCCGG-3'), 470 nt upstream from the CAT stop codon. A second round of amplification was carried out by nested PCR with oligonucleotide CATSG1 (5'-TGGCAGGGCGGGGGTAA-3') 18 nt upstream from the CAT stop codon and PWM5Eco. PCR amplifications were performed for 35 cycles of 30 s at 94oC, 1 min at 60oC and 1 min at 70oC in a final volume of 50 [mu]l containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl 2 , 100 [mu]g/ml BSA and 100 pmol of each primer. PCR products were resolved by gel electrophoresis in 1.5% agarose.

RESULTS

GARP gene loci

Previously we had isolated three lambda clones ([lambda]4.3, [lambda]4.4, [lambda]4.5) containing sequences homologous to cDNA P4 which encodes the GARP protein ( 15 ). Two cDNA P4-homologous regions are contained in [lambda]4.3, while [lambda]4.4 and [lambda]4.5 contain one such region each. Partial sequencing had shown that sequence identity was very high between the genes from the 4.3 and 4.4 loci, at least in the 3' region of the open reading frame ( 15 ). Further sequence analysis has now demonstrated a high degree of sequence similarity between the 5' ends of the GARP genes from each locus (Fig. 5 ). Subsequent analysis of the genomic clones showed that [lambda]4.5 was derived from the same locus as [lambda]4.3 (data not shown). Partial maps of the 4.3 and 4.4 GARP loci are shown in Figure 1 .

GARP transcription is sensitive to [alpha] -amanitin

We synthesised 32 P-labelled nascent transcript probes by in vitro run-on using nuclei pre-incubated with [alpha]-amanitin for 10 min on ice (Fig. 2 , + [alpha]-amanitin) or methanol, the solvent for the drug (Fig. 2 , - [alpha]-amanitin). The nascent transcript probes were hybridised to identical Southern blots of restriction digests of L29, a T.congolense cDNA clone encoding a ribosomal protein (lanes 1 and 5) (R. Bayne, unpublished), the P4 GARP cDNA clone ( 15 ) (lanes 2 and 6), a T.brucei [alpha]- and [beta]-tubulin DNA repeat unit ( 24 ) (lanes 3 and 7) and a T.brucei ribosomal DNA repeat unit ( 27 ) (lanes 4 and 8). The P4 GARP cDNA insert hybridised only with the probe synthesised in nuclei which had not been pre-incubated with [alpha]-amanitin (Fig. 2 , lane 6). There was no detectable hybridisation when the cDNA insert was hybridised with transcripts from [alpha]-amanitin-treated nuclei (Fig. 3 , lane 2). Hybridisation to T.brucei tubulin sequences was decreased also in the presence of the drug (Fig. 3 , compare lanes 3 and 7) showing that [alpha]-amanitin was inhibiting RNA polymerase II. There was no decrease in RNA polymerase I transcription of ribosomal DNA (lanes 4 and 8) as expected. Transcription of T.congolense L29 ribosomal protein gene(s), however may be insensitive to the drug since we found consistently that transcription of L29 sequences was not completely inhibited by [alpha]-amanitin (lanes 1 and 5).


Figure 2 . Nuclear run-on analysis of [alpha]-amanitin sensitivity of GARP transcription. + [alpha]-amanitin: Southern blot hybridised with 32 P-labelled nascent transcripts run-on in nuclei pre-incubated in the presence of 500 [mu]g/ml [alpha]-amanitin for 10 min on ice. - [alpha]-amanitin: Southern blot hybridised with 32 P-labelled transcripts run-on in nuclei pre-incubated with 100 [mu]l methanol, the solvent for the drug, for 10 min on ice. Lanes 1 and 4, Xho I digest of L29, a cDNA plasmid clone encoding a ribosomal protein (R. Bayne, unpublished); lanes 2 and 5; Pst I digest of P4 the GARP cDNA clone (15); lanes 3 and 6, Hin dIII digest of pTB[alpha],[beta]-T1 (an [alpha]- and [beta]-tubulin repeat unit clone) (24); lanes 4 and 8, Pst I digest of pR4, a ribosomal DNA repeat unit clone (25). Hybridisations were in 3* SSC at 55oC and blots were washed to 0.1* SSC at 65oC. Identical quantities of DNA are loaded in each pair of tracks and identical autoradiograph exposures are shown.


Figure 3 . Nuclear run-on analysis of transcription of the 5' ends of the 4.3 and 4.4 loci. (A) Map of the 5' end of the 4.3 GARP locus. (B) Map of the 5' end of the 4.4 GARP locus. The open boxes represent GARP coding regions. The horizontal thick black lines represent DNA homologous to the loci shown above subcloned into pBluescript (thin black lines). Abbreviations: E, Eco RI, Bs; Bst XI, Pv; Pvu II, H; Hin dIII. Numbers 1-4 refer to the digestion products of the subclones. P refers to the pBluescript plasmid portion of the subclones. (C) An ethidium bromide-stained gel of a Bst XI digest (there is a Bst XI site in the 5' polylinker of the plasmid) of the plasmid clone pE/Pv4.3garp. (D) Southern blot of the gel in C hybridised with 32 P-labelled nascent transcripts synthesised in vitro in procyclic T.congolense nuclei. (E) An ethidium bromide-stained gel of a Hin dIII digest of the plasmid clone pE/Pv4.4garp (there is a Hin dIII site in the 5' polylinker of the plasmid). (F) Southern blot of the gel in E hybridised with 32 P-labelled nascent transcripts synthesised in vitro in procyclic T.congolense nuclei. Hybridisations were in 3* SSC at 55oC and blots were washed to 0.1* SSC at 65oC.


Figure 4 . RNase protection analysis of the transcriptional start site for the 4.3 GARP gene locus. (A) Map of the 4.3 GARP gene locus and, below, the pBluescript subclone p4.35'flank, containing a PCR-amplified fragment stretching from the nt immediately 5' of the splice acceptor site for the 5'-most 4.3 GARP gene to the Eco RI site 1.1 kb upstream. Primers used to amplify this fragment introduced a Bam HI site at the 5' end and an Eco RI site at the 3' end. These are shown in Figure 5A as 5'E/Pv Bam HI and 3'E/Pv Eco RI which is equivalent to gsp2 but with a 5' flanking Eco RI site. Open boxes: GARP coding regions, closed box: PCR-amplified insert in the subclone pB/Epcr5'4.3; B and E, Bam HI and Eco RI sites generated by PCR at the ends of the inserted sequence in pB/Epcr5'4.3; flags: bacterial promoters T7 and T3 flanking the polylinker sequence in the pBluescript subclone; arrowhead: major protected fragment. Abbreviations are exactly as for Figure 1. (B) Sequencing gel showing fractionation by electrophoresis of RNase protected fragments. Products were run next to a sequencing ladder (ACGT) as a size marker. Lane 1, T.congolense total RNA hybridised with an antisense probe for the 5' flank of the 4.3 GARP gene; lane 2, E.coli total RNA hybridised with the same probe; lane 3, T.congolense total RNA hybridised with a sense probe for the 5' flank of the 4.3 GARP gene; lane 4, E.coli total RNA hybridised with the sense probe. M is a double-stranded DNA marker made by end-labelling a 1 kb ladder (Life technologies), and sizes are shown in bp. Abbreviations: T3, antisense RNA probe synthesised with the pB/Epcr54.3 plasmid template and T3 RNA polymerase; T7, sense RNA probe synthesised with the pB/Epcr54.3 plasmid template and T7 RNA polymerase; T.c., probe hybridised with total T.congolense RNA; E.c., probe hybridised with E.coli tRNA.


Figure 5 . Sequence of the putative promoter region, 3' UTR and a portion of the intergenic region downstream for the 4.3 GARP locus. (A) The putative promoter region from the Eco RI site 1.1 kb upstream of the cDNA start to the transcriptional start site indicated with a small arrowhead at 645 bp; the 5 UTR including the splice acceptor region which stretches from the square bracket at 834 bp to the splice acceptor site shown in bold type at 1088 nt; the cDNA start site indicated with a large arrowhead at 1110 bp, followed by the ATG start codon (boxed) at 1149 bp and 50 bp downstream of the GARP start codon. The Eco RI and Bst XI sites are underlined and the primers used to amplify the region 5' of the splice acceptor site by PCR or the primers used in 5' RT-PCR to locate the transcriptional start site are indicated by bold arrows below the sequence. The primer 3'E/Pv Eco RI exactly overlaps the primer gsp2 with an Eco RI site attached at the 5' end. The region bearing 96% homology with the 4.4 locus starts at the square bracket and is indicated with a vertical bar to the right of the sequence. The remainder of the sequence 5' has 48% homology with the 4.4 locus. Polypyrimidine tracts of more than 5 nt length are overlined. (B) The 3' UTR of the 5'-most GARP gene and a portion of the downstream intergenic region. The sequence begins at the TGA (shown in bold) stop codon for the GARP coding region and the Bam HI site used for subcloning the 3' UTR of the GARP gene is overlined. The second primer used to amplify the GARP 3' UTR by 3' RT-PCR is indicated by a bold arrow below the sequence. Polyadenylation sites are indicated with arrowheads. The 16 nt motif conserved between PARP and GARP cDNAs is boxed. Polypyrimidine tracts in the 5' portion of the intergenic region are underlined and YAG trinucleotides are circled. The next open reading frame is 2.6 kb downstream.



Promoter localisation

We performed nuclear run-on analysis to determine whether there was a transcriptional gap, and therefore a putative promoter located 5' of the 4.3 or 4.4 GARP loci. The 32 P-labelled nascent transcripts run-on in nuclei isolated from procyclic T.congolense were hybridised to Southern blots of a Hin dIII digest of pE/Pv4.4 (the inserted DNA in this subclone is a Pvu II fragment containing the Eco RI- Pvu II fragment shown in Figure 1 but flanked 5' with a Pvu II- Eco RI fragment from the very 3' end of the left hand arm of the lambda clone. The DNA is inserted in the Hin cII site in pBluescript, thus the second Hin dII site is in the 5' polylinker of the plasmid) (Fig. 3 B and E) or to a Bst XI digest (there is a Bst XI site in the 5' polylinker of the plasmid) of pE/Pv4.3 (Fig. 3 A and C). For the 4.4 locus, hybridisation was detected to both Hin dIII fragments (Fig. 3 F) indicating that transcription occurs across this region. The larger Hin dIII fragment contains 2960 bp of plasmid sequence plus 1070 bp of GARP-related sequence, and we cannot discount the possibility that there may be another gene 5' of the GARP gene in the 4.4 locus but part of another transcription unit. In this case a small gap in transcription may be present within this fragment which would not be detected in this crude assay. For the 4.3 locus we detected hybridisation only to the larger Bst XI fragment (2.96 kb of plasmid DNA and 728 bp of GARP-related sequence) (Fig. 3 D). The run-on probe did not hybridise to plasmid DNA alone (data not shown). Since we did not detect hybridisation to the smaller, upstream fragment (572 bp), a transcriptional gap must exist upstream of the 4.3 GARP locus, and it is reasonable to assume that transcription of the 4.3 GARP locus initiates, and a promoter for GARP gene transcription may be present, within the cloned region 5' of the 4.3 GARP genes around or downstream of the Bst XI site.

Transcription initiation site for the 4.3 locus 5 ' GARP gene

Having located a transcriptional gap 5' of the 4.3 5'-most GARP gene, we localised the transcription initiation site by RNase protection (Fig. 4 ) and 5' RT-PCR. For RNase protection analysis we used the recombinant pBluescript plasmid template, p4.35'flank. The inserted DNA in this subclone is homologous to the 1.1 kb of sequence flanking the splice acceptor site in [lambda] 4.3 (Fig. 5 A) and was amplified by PCR using primers 5'E/Pv Bam HI and 3'E/Pv Eco RI (Fig. 5 A) to generate a Bam HI site at the 5' end and an Eco RI site at the 3' end. This subclone was used to synthesise in vitro, labelled sense transcripts (T7 RNA polymerase), or antisense transcripts (T3 RNA polymerase) homologous to the putative 5' end of the GARP transcription unit. The sense and antisense radiolabelled transcripts were hybridised to either total T.congolense RNA or to Escherichia coli tRNA. Following RNase digestion of hybrids and fractionation of digestion products on a sequencing gel, a major protected fragment of around 440 bases and a minor product at around 330 bases were observed when the antisense T3 RNA polymerase-synthesised transcripts from p4.35'flank were hybridised with total T.congolense RNA (Fig. 4 B, lane 1) but not when the same transcripts were hybridised with E.coli tRNA (Fig. 4 B, lane 2). Hybridisation of T7 RNA polymerase-synthesised sense transcripts with either total T.congolense RNA (Fig. 4 B, lane 3) or E.coli tRNA (Fig. 4 , lane 4) gave no protected product, as expected. If the large protected fragment represents a primary transcript for the 5' end of the 4.3 GARP locus then this places the transcription initiation site around 460 bp upstream of the start of the cDNA. The minor protected fragment may be a degradation product of the major fragment; it may represent transcription from a secondary promoter; or it may be a fragment from another GARP locus which we have not yet identified, that has a shorter region of homology with 5' sequences of the 4.3 GARP locus.

Next we used 5'RT-PCR to confirm this result and to locate the specific nucleotide(s) where transcription initiated. The oligonucleotide used to direct first strand cDNA synthesis was a 25mer homologous to nucleotides 50-25 3' of the ATG start codon of the 4.3 GARP gene (GARPgsp1; Fig. 5 A). Two major products were obtained, one at around 130 nt corresponding to the spliced mature RNA and one at around 550 nt (data not shown). Two further oligonucleotides (GARPgsp2, gsp3) were used to prime two subsequent rounds of PCR, and these are indicated by long arrows below the sequence in Figure 5 A. A single major PCR product was obtained (around 450 bp) and amplified DNAs were cloned and sequenced. All five clones sequenced gave the same initiation site corresponding to a G residue 466 nt upstream of the cDNA start site indicated by the small arrowhead in Figure 5 A. There are no significant open reading frames within the entire 1.1 kb fragment 5' of the cDNA start and stop codons are present in all frames.

GARP splice acceptor and polyadenylation sites

The site for addition of the spliced leader sequence was predicted to be about 20 bp upstream of the start of the cDNA homologous to the GARP gene in the 4.4 locus ( 15 ). RNase protection studies and 5'RT-PCR indicated that a spliced leader addition sequence was located at the same distance upstream of the first GARP gene in the 4.3 locus (AG in bold type at position 1088 in Fig. 5 A) (data not shown). Sequencing upstream of the AG dinucleotide splice acceptor site for both loci revealed that there was a 258 bp region with 96% sequence identity between the two GARP gene loci (running 3' from the square bracket in Fig. 5 A) 5' of which the homology dropped to 48% identity. Since these homologous sequences contain the splice acceptor sites for the 5' GARP genes in both loci it is probable that these regions contain the sequences necessary to direct trans -splicing of the GARP genes in T.congolense . We used 3'RT-PCR to determine where GARP transcripts were polyadenylated. Figure 5 B shows the 3' UTR and some 350 bp of intergenic region downstream. First strand cDNA synthesis was primed with oligo [dT] then two nested oligonucleotides, the first homologous to a sequence at the 3' end of the GARP coding region and the second homologous to a sequence at the 5' end of the 3' UTR of GARP (Fig. 5 B) were used to prime two subsequent rounds of PCR. A single major PCR product was obtained and amplified DNAs were cloned and sequenced. We found a range of sites of polyadenylation within a 25 nt region in the 3' UTR of GARP mRNAs which was located 468-493 nt downstream of the translation stop codon (arrowheads in Fig. 5 B). Sequencing of part of the intergenic region downstream revealed a distribution of sequence motifs (underlined and circled in Fig. 5 B) similar to those found for intergenic regions in T.brucei ( 4 ).

Functional analysis of sequences controlling GARP gene expression by transient transfection of trypanosomes

In order to test whether the GARP putative promoter region was functional and to determine whether sequences involved in regulating GARP gene expression in T.congolense could be recognised in T.brucei, we carried out a series of transient transfection assays (Fig. 6 ). We compared the ability of the procyclin/PARP promoter and the putative GARP promoter to drive expression of a CAT reporter gene in the constructs shown in Figure 6 A and B. When we transiently transfected T.congolense cells with the construct p5'garpCAT3'garp (644 bp of sequence 5' of the transcription start site and the entire putative splice acceptor site with the insert of pgarp3'utr as the 3' UTR) we could not detect CAT activity, even with a range of protease inhibitors included in the transfection buffer and the cell lysis buffer, but CAT RNA was readily detectable (Fig. 6 A, lane 4). This indicated that we had indeed identified a region of sequence 5' of the first GARP gene in the 4.3 locus which could act as a promoter in this assay. Either CAT enzyme is highly unstable in T.congolense cells or the CAT RNA is not able to be translated. Thus, rather than assaying CAT enzyme activity we analysed the abundance of CAT transcripts in the transiently transfected cells. The GARP constructs numbered 1, 2 and 4 in Figure 6 A contained a GARP 3' UTR isolated from cDNA P4. In T.brucei it has been shown that, in transient transfection experiments, inclusion of only the 3' UTR of a procyclin/PARP cDNA downstream of the CAT gene is not sufficient to specify positionally accurate polyadenylation of CAT transcripts ( 4 , 5 , 20 ). However, it does allow polyadenylation of PARP transcripts but at a site around 100 bases 5' of the site used in vivo ( 20 ). For T.congolense we found by 3' RT-PCR that the 3' UTR used in the transient transfection studies did direct polyadenylation but at a novel site 120 bases 5' of the polyadenylation site used in the cDNA clone P4. Inclusion of a further 620 bp 3' of the endogenous polyadenylation site which includes part of the intergenic region flanking the next GARP gene downstream had no effect on CAT RNA abundance in transiently transfected cells (data not shown), but still did not allow us to detect CAT enzyme activity. This intergenic region includes several sequences similar to the types of signal (an extensive polypyrimidine tract, an AG dinucleotide putative splice site flanked 3' by a short polypyrimidine tract, Fig. 5 B) which have been shown to be important for regulation of polyadenylation in T.brucei ( 4 ).


Figure 6 . Northern blot analysis of CAT reporter gene expression from the GARP promoter. (A) Schematic illustrations of the GARP-based constructs: 1, p5'parpCAT3'garp; 2, p-CAT3'garp; 3, p5'garpCAT3'parp; 4, p5'garpCAT3'garp. (B) Schematic illustrations of the PARP-based constructs: 5, p5'garpCAT3'parp; 6, p-CAT3'parp; 7, p5'parpCAT3'garp; 8, p5'parpCAT3'parp. Abbreviations: prom, promoter; sa, splice acceptor region; CAT, chloramphenicol acetyl transferase gene; 3', 3' UTR. (C) Northern blot analysis of total RNA isolated from 10 7 T.congolense cells/lane transiently transfected with 50 [mu]g/10 8 cells of the DNA constructs schematically illustrated on the left in A. (D) Northern blot analysis of total RNA isolated from 10 7 T.brucei cells/lane transiently transfected with 50 [mu]g/10 8 cells of the DNA constructs schematically illustrated on the left in B. Both Northern blots were hybridised with a 32 P-labelled CAT antisense RNA in 50% formamide, 5* SET (1*SET is 150 mM NaCl, 10 mM Tris-HCl pH 7.5 and 1 mM EDTA), 5* Denhardt's solution, 50 [mu]g/ml tRNA, 0.5% SDS at 55oC for 16 h. Blots were washed to 0.1* SET, 0.5% SDS. (E) and (F) Rehybridisation of the blots in C and D with a 32 P-labelled T.brucei actin probe prepared by random hexanucleotide priming of the gel-purified insert from pActine (26). The blots in C and D were stripped of probe and autoradiographed overnight to check that no hybridisation remained before rehybridisation. Hybridisation was in 50% formamide, 5* SSC, 0.1% SDS at 42oC for 16 h. The blot in E (a cross-species hybridisation) was washed to 3* SSC at 65oC while the blot in F (homologous hybridisation) was washed to 0.1* SSC at 65oC.

As negative controls for promoter activity we used the same plasmids from which we removed the promoter regions but retained the splice acceptor regions: for GARP this was the region downstream of the square bracket in Figure 5 A (p-CAT3'congo; Figure 6 A lane 2). For PARP the splice acceptor region was the Sma I- Hin dIII fragment from pJP44 (p-CAT3'parp; Fig. 6 B lane 6). No CAT transcripts were detected in either T.congolense or T.brucei cells transiently transfected with these constructs (Fig. 6 C, lane 2, Fig. 6 D, lane 6). Next we asked if the procyclin/PARP promoter could direct CAT expression in transient transfection of T.congolense and conversely, if the GARP putative promoter region was operative in driving CAT gene expression in transient transfection of T.brucei (Fig. 6 A construct 1, Fig. 6 B construct 5). Initial studies using p5'parpCAT3'parp to transiently transfect T.congolense and p5'garpCAT3'garp to transiently transfect T.brucei yielded no CAT RNA (data not shown). Similarly, Figure 6 C lane 1 shows that steady-state levels of CAT transcripts were not produced using the PARP promoter/splice acceptor site in p5'parpCAT3'garp in T.congolense transient transfection. Figure 6 D lane 5 shows that no CAT transcripts were detected in T.brucei cells transiently transfected with the GARP promoter construct p5'garpCAT3'parp. Finally, we had observed that the 3' UTRs of GARP and procyclin/PARP transcripts shared a 16mer motif at approximately the same distance upstream of the poly(A) addition site ( 15 ). This suggested that in both species, a similar mechanism might operate to regulate procyclin/PARP and GARP gene expression mediated through the 3' end of the mRNAs. It was therefore possible that sequences at the 3' end of the gene were not entirely species-specific. To test this possibility we exchanged the 3' UTRs of the GARP and procyclin/PARP cDNAs in the constructs p5'parpCAT3'parp and p5'garpCAT3'garp to give p5'parpCAT3'garp and p5'garpCAT3'parp. The result shown in Figure 6 C, lane 3 indicates that replacement of the GARP gene 3' UTR with the corresponding region of the procyclin/PARP gene does not allow efficient expression of CAT in transient transfection experiments in T.congolense . Similarly, Figure 6 D, lane 7 indicates that replacement of the procyclin/PARP 3' UTR by the GARP gene 3' end does not allow efficient expression of CAT in transient transfection of T.brucei . For all these experiments, replicate transient transfection experiments were always very reproducible. We also assayed CAT activity in T.brucei , transiently transfected with the constructs shown in Figure 6 B and obtained results consistent with those obtained by measuring CAT RNA abundance in Figure 6 D. Rehybridisation of the Northern blots in Figure 6 C and D with a T.brucei actin probe showed that failure to detect CAT transcripts in tracks 1-3 and 5-7 was not due to lack of RNA in each track (Fig. 6 E and F). These experiments demonstrate that in both flanks there are significant species-specific differences in sequences regulating gene expression in T.brucei and T.congolense .

DISCUSSION

We have shown that transcription of GARP genes in T.congolense is sensitive to [alpha]-amanitin. We have identified a gap in transcription upstream of the 5'-most GARP gene in the 4.3 locus and localised a transcription initiation site for this gene. The putative promoter thus defined appears to be able to drive transcription of a CAT reporter gene when the gene is flanked 5' by a GARP gene splice acceptor site and 3' by a GARP gene 3' UTR. This is the first report of the cloning and characterisation of a promoter for a gene in T.congolense and the first identified promoter in trypanosomes which directs RNA polymerase II-like transcription.

The GARP putative promoter region has no significant homology with any other T.brucei promoter sequence and especially with the procyclin/PARP promoter. It is located much further upstream (504 bp) of the GARP start codon in T.congolense than the promoter reported for procyclin/PARP genes in T.brucei, which is around 86 bp upstream of the start codon of the first gene in the PARP A locus ( 16 ). The AG dinucleotide is located 60 nt upstream of the translation start codon for both the 4.3 and 4.4 GARP loci while for the 5' procyclin/PARP gene in the PARP A locus the distance is only 30 nt ( 34 ). In many eukaryotes the splice acceptor site at an AG dinucleotide is preceded 5' with a pyrimidine-rich tract and it has been shown that this is also the case for some kinetoplastid genes ( 2 , 3 , 35 , 36 ) including procyclin/PARP genes where there is a 26/29 pyrimidine tract very close to the splice acceptor site ( 34 ). We have not observed extensive polypyrimidine tracts within the putative splice acceptor regions for the GARP loci we have studied, although for the 4.3 locus the region 5' of the splice acceptor site is 66% TC-rich over the first 100 nt. There is a 9-pyrimidine tract 17 nt upstream of the splice acceptor site and two further short pyrimidine tracts (>5 nt) 31 and 107 nt upstream (overlined, Fig. 5 A). Mutational analysis will be necessary to determine the importance of these sequences in trans -splicing in T.congolense . However, polypyrimidine motifs may not be entirely necessary since experiments with deletion mutations in the dihydrofolate reductase-thymidylate synthase/DST intergenic region of Leishmania major have shown that splice acceptor sites lacking a strong polypyrimidine tract immediately upstream can still be used efficiently ( 2 ).

We have also mapped the polyadenylation sites for the GARP genes in T.congolense . While procyclin/PARP transcripts have a single major site of polyadenylation ( 4 , 5 ) GARP transcripts appear to be polyadenylated differentially over a region of 20 bases. We cannot rule out the possibility that the different sites are specific to different individual GARP genes. Such microheterogeneity has also been observed for genes in Leishmania ( 2 , 37 - 40 ) and T.brucei ( 3 , 41 ) but in the absence of information on other genes in T.congolense it is not possible to determine whether this is a feature of polyadenylation in this species or whether it is peculiar to GARP transcripts. Recent studies have indicated that accurate polyadenylation of transcripts from polycistronic transcription units in Kinetoplastida is dependent on sequence motifs, located downstream of the gene sequence, in the intergenic region ( 2 - 5 ). One study where the nt sequences from several intergenic regions in T.brucei were compared, revealed a similar organisation of related motifs at a fixed distance downstream of the polyadenylation sites for each gene ( 4 ). Of the four elements identified which were proposed potentially to contribute to specification of accurate polyadenylation three are also present in the intergenic region downstream of the 5'-most GARP gene in the 4.3 locus in T.congolense . These are (i) an intervening sequence of 80 nt between the poly(A) addition site and (ii) a polypyrimidine tract followed by the trinucleotide YAG, and (iii) a further polypyrimidine tract a short distance downstream followed by another YAG sequence (Fig. 4 B). Thus although our transient transfection experiments suggest that there are significant cross-species differences in sequences regulating gene expression in the two African trypanosomes, there may be conservation of intergenic region signals directing polyadenylation between the two species.

Although we were unable to obtain and assay CAT activity from transiently transfected T.congolense , CAT transcripts were readily detectable. Either CAT enzyme is highly unstable in T.congolense cells, inactive in extracts, or the CAT RNA is not able to be translated. In the constructs we used initially, only the GARP 3 UTR was used to specify polyadenylation. CAT transcripts produced were polyadenylated but not at the wild-type site. It is possible that aberrantly polyadenylated transcripts could be inefficiently translated leading to undetectable levels of CAT enzyme activity.

We did not know whether T.congolense followed the pattern for T.brucei and Leishmania, where a downstream splice acceptor site and pyrimidine-rich sequences downstream of the polyadenylation site are required for correct polyadenylation of transcripts (although our sequence analysis suggested this may be true). Therefore, we tested whether inclusion of a portion of the first intergenic region in the 4.3 GARP locus (Fig. 4 B), including the sequence motifs similar to those necessary for accurate polyadenylation of procyclin/PARP transcripts in T.brucei, would result in our being able to detect CAT activity. However, when we included in our constructs the GARP 3' UTR and a further 650 nt downstream (the insert in the construct pCG4.33garp, Fig. 1 ) we still obtained no CAT activity (data not shown). CAT expression must be blocked at translation or downstream in these cells.

Our results indicate that, despite the assumed relatively close species relationship between T.congolense and T.brucei , sequences important in regulating expression of the major surface antigen of the procyclic form in these organisms are rather different. We found that the T.congolense GARP promoter was inactive in driving CAT expression in transient transfection assays in T.brucei where CAT constructs contained a GARP splice acceptor site but a PARP 3' UTR. It is possible that in T.brucei the GARP promoter is active, but the GARP splice acceptor site inactive, leading to the production of unstable primary transcripts for CAT. Similarly, the apparent inactivity of the procyclin/PARP promoter in T.congolense could be due to the PARP splice acceptor region not being recognised. However, a construct with a GARP putative promoter region and a PARP splice acceptor site gave no CAT RNA or CAT activity in T.brucei (data not shown), suggesting that the source of the splice acceptor site used has no effect in these constructs. The fact that GARP and procyclin/PARP genes are transcribed by different RNA polymerases may be a more likely cause of promoter inactivity across species.

CAT transcripts produced in our constructs were not polyadenylated at the correct site in either the GARP or PARP 3' UTRs, but this is irrelevant in these experiments since the GARP and PARP promoters gave high levels of CAT RNA with these 3' UTRs in T.congolense and T.brucei respectively. We observed that the 3' UTR of procyclin/PARP and GARP transcripts are not interchangeable between species in transient transfection assays. We had noted previously that there existed a conserved 16 nt sequence motif situated at approximately the same distance with respect to the polyadenylation site for the GARP and procyclin/PARP genes ( 15 ). In T.brucei while one study showed that the 16mer was necessary for efficient translation of PARP/procyclin mRNAs ( 18 ) another study, using a transient transfection approach, found that CAT transcripts whose truncated 3' UTR lacked the 16mer seemed to be translated efficiently at least in procyclic cells ( 20 ). The 16mer may have a role in GARP gene expression but since the 3'UTRs of both procyclin/PARP and GARP genes are not recognised in the heterologous system, the conserved motif cannot be sufficient for any regulation of gene expression exerted by the 3' end of the mRNAs. Finally, we have observed that GARP mRNA is readily detected in bloodstream form T.congolense although the protein is not produced (D. Jefferies, unpublished). This is a very different situation from that for procyclin/PARP where transcripts are barely detectable in bloodstream form T.brucei . Our observation indicates that, for GARP expression, life cycle stage-specific regulation must be achieved at the translational or post-translational level. This observation may help to explain why GARP is transcribed by an [alpha]-amanitin sensitive RNA polymerase. RNA polymerase II appears to transcribe genes whose expression is constitutive in the trypanosome life cycle as is the case for GARP in T.congolense . Procyclin/PARP transcription in regulated during the life cycle, at least partly ( 42 , 43 ), metacyclic VSG genes are truly transcriptionally regulated ( 44 ), while bloodstream VSG gene expression sites are transcriptionally regulated, especially during the bloodstream phase of the life cycle ( 45 ). All of these genes which encode major surface antigens are transcribed by RNA polymerase I ( 46 ), and this may be a crucial factor in singling out these genes for at least some degree of transcriptional regulation.

ACKNOWLEDGEMENTS

We thank Carole Ross (Centre for Tropical and Veterinary Medicine, Edinburgh) for provision of trypanosome stocks and cultures and for advice on culturing. This work was supported by the Wellcome Trust. J.D.B. is a Wellcome Trust Senior Lecturer.

REFERENCES

1 Clayton,C. (1992) Prog. Nucleic Acid Res.Mol.Biol., 43, 37-65.

2 LeBowitz,J.H., Smith,J., Rusche,L. and Beverley,S.M. (1994) Genes Dev., 7, 996-1007.

3 Matthews,K.R., Tschudi,C. and Ullu,E. (1994) Genes Dev., 8, 491-501.

4 Schürch,N., Hehl,A., Vassella,E., Braun,R. and Roditi,I. (1994) Mol. Cell. Biol., 14, 3668-3675.

5 Hug,M., Hotz,H., Hartmann,C. and Clayton,C. (1994) Mol. Cell. Biol., 14, 7428-7435. MEDLINE Abstract

6 Graham,S.V. (1995) Parasitol. Today, 11, 217-223.

7 Vickerman,K. (1985) Br. Med. Bull., 41, 105-114.

8 Cross,G.A.M. (1990) Annu. Rev. Immunol., 8, 83-110.

9 Roditi,I., Carrington,M. and Turner,M. (1987) Nature, 325, 272-274.

10 Roditi,I., Schwarz,H., Pearson,T.W., Beecroft,R.P., Liu,M.K., Richardson,J.P., Buhring,H.J., Pleiss,J., Bulow,R., Williams,R.O. and Overath,P. (1989) J. Cell Biol., 108, 737-746. MEDLINE Abstract

11 Mowatt,M.R. and Clayton,C.E. (1987) Mol. Cell. Biol., 7, 2838-2844. MEDLINE Abstract

12 Richardson,J.P., Beecroft,R.P., Tolson,D.L., Liu,M.K. and Pearson,T.W. (1988) J. Cell Biol., 108, 737-746. MEDLINE Abstract

13 Beecroft,R.P., Roditi,I. and Pearson,T.W. (1993) Mol. Biochem. Parasitol., 61, 285-294.

14 Hehl,A., Pearson,T., Barry,J.D., Braun,R. and Roditi,I. (1995) Mol. Biochem. Parasitol., 70, 45-58.

15 Bayne,R.A.L., Kilbride,E.A., Lainson,F.A., Tetley,L. and Barry,J.D. (1993) Mol. Biochem. Parasitol., 61, 295-310. MEDLINE Abstract

16 Sherman,D.R., Janz,L., Hug,M. and Clayton,C. (1991) EMBO J., 10, 3379-3386. MEDLINE Abstract

17 Brown,S.D., Huang,J. and Van der Ploeg,L.H.T. (1992) Mol. Cell. Biol., 12, 2644-2652. MEDLINE Abstract

18 Hehl,A., Vassella,E., Braun,R. and Roditi,I. (1994) Proc. Natl Acad. Sci. USA, 91, 370-374.

19 Vassella,E., Braun,R. and Roditi,I. (1994) Nucleic Acids Res., 22, 1359-1364. MEDLINE Abstract

20 Hug,M., Carruthers,V.B., Hartmann,C., Sherman,D.S., Cross,G.A.M. and Clayton,C. (1993) Mol. Biochem. Parasitol., 61, 87-96. MEDLINE Abstract

21 Ross,C.A., Gray,M.A., Taylor,A.M. and Luckins,A.G. (1985) Acta Trop., 42, 113-122.

22 Gray,M.A., Ross,C.A., Taylor,A.M. and Luckins,A.G. (1984) Acta Trop., 41, 343-353.

23 Gray,M.A., Ross,C.A., Taylor,A.M., Tetley,L. and Luckins,A.G. (1985) Acta Trop., 42, 99-111.

24 Thomashow,L.S., Milhausen,M., Rutter,W.J. and Agabian,N. (1983) Cell, 32, 35-43.

25 Kooter,J.M. and Borst,P. (1984) Nucleic Acids Res., 12, 9457-9472. MEDLINE Abstract

26 Ben Amar,M.F., Pays,A., Tebabi,P., Dero,B., Seebeck,T., Steinert,M. and Pays,E. (1988) Mol. Cell. Biol., 8, 2166-2176. MEDLINE Abstract

27 Kooter,J.M., van der Spek,H.J., Wagter,R., d'Oliveira,C.E., van der Hoeven,F., Johnson,P.J. and Borst,P. (1987) Cell, 51, 261-272. MEDLINE Abstract

28 Auffray,C. and Rougeon,F. (1980) Eur. J. Biochem., 107, 303-314. MEDLINE Abstract

29 Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular cloning: A laboratory manual, Cold Spring Laboratory Press, Cold Spring Harbor, NY.

30 Feinberg,A.P. and Vogelstein,B. (1983) Anal. Biochem., 132, 6-13. MEDLINE Abstract

31 Bellofatto,V. and Cross,G.A.M. (1989) Science, 244, 1167-1169. MEDLINE Abstract

32 Zomerdijk,J.C.B.M., Ouellette,M., Ten Asbroek,A.L.M.A., Kieft,R., Bommer,A.M.M., Clayton,C.E. and Borst,P. (1990) EMBO J., 9, 2791-2801. MEDLINE Abstract

33 Seed,B. and Sheen,J.-Y. (1988) Gene, 67, 271-277. MEDLINE Abstract

34 Huang,J. and Van der Ploeg,L.H.T. (1991) EMBO J., 10, 3877-3885. MEDLINE Abstract

35 Curotto de Lafaille,M.A., Laban,A. and Wirth,D.F. (1992) Proc. Natl Acad. Sci. USA, 89, 2703-2707. MEDLINE Abstract

36 Layden,R.E. and Eisen,H. (1988) Mol. Cell. Biol., 8, 1352-1360. MEDLINE Abstract

37 Landfear,S.M., Miller,S.I. and Wirth,D.F. (1986) Mol. Biochem. Parasitol., 21, 235-245. MEDLINE Abstract

38 Kapler,G.M., Coburn,C.M. and Beverley,S.M. (1990) Mol. Cell. Biol., 10, 1084-1094. MEDLINE Abstract

39 Flinn,H.M. and Smith,D.F. (1992) Nucleic Acids Res., 20, 755-762. MEDLINE Abstract

40 Ramamoorthy,R., Donelson,J.E., Paetz,K.E., Maybodi,M., Roberts,S.C. and Wilson,M.E. (1992) J. Biol. Chem., 267, 1888-1895. MEDLINE Abstract

41 Tschudi,C. and Ullu,E. (1988) EMBO J., 7, 455-463. MEDLINE Abstract

42 Pays,E., Coquelet,H., Tebabi,P., Pays,A., Jefferies,D., Steinert,M., Koenig,E., Williams,R.O. and Roditi,I. (1990) EMBO J., 9, 3145-3151. MEDLINE Abstract

43 Berberof,M., Vanhamme,L., Tebabi,P., Pays,A., Jefferies,D., Welburn,S. and Pays,E. (1995) EMBO J., 14, 2925-2934. MEDLINE Abstract

44 Graham,S.V. and Barry,J.D. (1995) Mol. Cell. Biol., 15, 5945-5956. MEDLINE Abstract

45 Rudenko,G., Blundell,P.A., Taylor,M.C., Kieft,R. and Borst,P. (1994) EMBO J., 13, 5470-5482.

46 Chung,H.-M., Lee,M.G.-S. and Van der Ploeg,L.H.T. (1992) Parasitol. Today, 8, 414-418.


Return

* To whom correspondence should be addressed

+ Present address: The Roslin Institute, Roslin, Midlothian EH25 9PT, UK
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eukaryot CellHome page
S. Martinez-Calvillo, D. Nguyen, K. Stuart, and P. J. Myler
Transcription Initiation and Termination on Leishmania major Chromosome 3
Eukaryot. Cell, April 1, 2004; 3(2): 506 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Mahmood and D. S. Ray
Nulear Extracts of Crithidia fasciculata Contain a Factor(s) That Binds to the 5'-Untranslated Regions of TOP2 and RPA1 mRNAs Containing Sequences Required for Their Cell Cycle Regulation
J. Biol. Chem., September 11, 1998; 273(37): 23729 - 23734.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (166K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Graham, S.
Right arrow Articles by Barry, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graham, S.
Right arrow Articles by Barry, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?